Matches in Wikidata for { <http://www.wikidata.org/entity/Q64150563> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q64150563 description "clinical trial" @default.
- Q64150563 description "ensayu clínicu" @default.
- Q64150563 description "klinisch onderzoek" @default.
- Q64150563 description "клінічне випробування" @default.
- Q64150563 description "կլինիկական փորձարկում" @default.
- Q64150563 name "Ixabepilone in Treating Participants With Significant Residual Disease of HER2/Neu Negative Invasive Breast Cancer After Systemic Therapy" @default.
- Q64150563 type Item @default.
- Q64150563 label "Ixabepilone in Treating Participants With Significant Residual Disease of HER2/Neu Negative Invasive Breast Cancer After Systemic Therapy" @default.
- Q64150563 prefLabel "Ixabepilone in Treating Participants With Significant Residual Disease of HER2/Neu Negative Invasive Breast Cancer After Systemic Therapy" @default.
- Q64150563 P1050 Q64150563-E0E926D9-BA90-4E85-8506-A7829F899B6D @default.
- Q64150563 P1132 Q64150563-9FCCE376-E4C4-4701-97B7-BF080C11A70C @default.
- Q64150563 P1476 Q64150563-FC16922D-9958-4A0A-973E-4C9342983995 @default.
- Q64150563 P17 Q64150563-BE1121DB-388E-4C11-A3AF-1F2061C055C4 @default.
- Q64150563 P2899 Q64150563-0148FC32-97E0-4E78-A1F7-90E7AECFAEDA @default.
- Q64150563 P3098 Q64150563-99A5E992-E310-45B3-B42D-E7ED7134C0B0 @default.
- Q64150563 P31 Q64150563-280547B7-94F1-4087-9F39-270A9BDE99DE @default.
- Q64150563 P580 Q64150563-C3B66B93-8FC5-4525-B8B0-91DDBD152170 @default.
- Q64150563 P582 Q64150563-DDB5D49E-6F4F-436E-9C62-4E29DB82A8F2 @default.
- Q64150563 P6099 Q64150563-F6322878-9EB9-497E-9D8A-863ABA25A976 @default.
- Q64150563 P6153 Q64150563-C5F520A6-468B-42F5-A78E-45119BC183D4 @default.
- Q64150563 P8363 Q64150563-B9F3EA4C-D031-43B4-87C9-34FFA24CA6B4 @default.
- Q64150563 P1050 Q33525 @default.
- Q64150563 P1132 "+116" @default.
- Q64150563 P1476 "A Phase II Randomized Study of Ixabepilone vs. Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2/Neu-Negative Breast Cancer" @default.
- Q64150563 P17 Q30 @default.
- Q64150563 P2899 "+18" @default.
- Q64150563 P3098 "NCT00877500" @default.
- Q64150563 P31 Q30612 @default.
- Q64150563 P580 "2009-03-30T00:00:00Z" @default.
- Q64150563 P582 "2020-04-30T00:00:00Z" @default.
- Q64150563 P6099 Q42824440 @default.
- Q64150563 P6153 Q30254232 @default.
- Q64150563 P8363 Q78089383 @default.